Palmoplantar psoriasis

Clin Dermatol. 2017 Jan-Feb;35(1):19-27. doi: 10.1016/j.clindermatol.2016.09.004. Epub 2016 Sep 10.

Abstract

Palmoplantar psoriasis refers to a localized psoriasis variant. The disease can be associated with many clinical forms, including predominantly pustular lesions to thick scaly, hyperkeratotic plaques, or an overlapping of both of them. Palmoplantar psoriasis accounts for 3-4% of all psoriasis cases in most studies. Although it is localized only on the palms and the soles, the fissures, the hardening of the tissue, and hyperkeratosis affect daily routine activities. Taking the body surface area as a measure of severity can sometimes be misleading. In clinical practice, the level of functional impairment should be taken into account rather than relying on traditional instruments to evaluate the severity. Palmoplantar psoriasis is usually managed with topical therapy as a first step. Systemic therapy is needed when the topicals fail or when the disease becomes more severe. Sometimes, biologic agents are required for adequate maintenance of clinical response.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Biological Products / therapeutic use*
  • Coal Tar / therapeutic use
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / therapeutic use*
  • Foot Dermatoses / etiology
  • Foot Dermatoses / therapy*
  • Hand Dermatoses / etiology
  • Hand Dermatoses / therapy*
  • Humans
  • Nicotinic Acids / therapeutic use
  • PUVA Therapy
  • Psoriasis / complications*
  • Psoriasis / diagnosis
  • Psoriasis / therapy*

Substances

  • Adrenal Cortex Hormones
  • Biological Products
  • Dermatologic Agents
  • Nicotinic Acids
  • Coal Tar
  • tazarotene